je.st
news
Tag: patients
A better way to care for dementia patients
2018-03-16 01:15:11| BBC News | Business | UK Edition
Infrared technology and artificial intelligence offer a better way to take care of dementia patients. It can scan their vital signs 24 hours a day.
Insurers should do more to help cancer patients, says FCA
2017-06-20 13:37:29| BBC News | Business | UK Edition
In one case a nurse with cancer was quoted 2,800 for travel insurance for a holiday to Dubai.
Tags: says
cancer
patients
insurers
Jakarta bird flu hospital overwhelmed with patients
2017-06-19 11:55:28| A1AWEB Internet Advertising, Website Creation, Marketing, Promotion, SEO
Tags: hospital
patients
bird
flu
Locked-in ALS patients get a voice thanks to this new mind-reading machine
2017-02-07 20:50:34| Extremetech
Researchers from Europe have used a brain-computer interface to communicate with four completely locked-in ALS patients. The post ‘Locked-in’ ALS patients get a voice thanks to this new mind-reading machine appeared first on ExtremeTech.
European Commission Approves KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Have High PD-L1 Expression with No EGFR or ALK Positive Tumor Mutations
2017-01-31 22:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Approval Based on Data Showing Improved Overall Survival and Progression-Free Survival with KEYTRUDA Compared to Chemotherapy First Anti-PD-1 Therapy Approved in Europe for Previously Untreated Patients with Metastatic NSCLC KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the European Commission has approved KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the first-line treatment of metastatic non-small cell lung cancer (NSCLC) in adults whose tumors have high PD-L1 expression (tumor proportion score [TPS] of 50 percent or more) with no EGFR or ALK positive tumor mutations. Language: English Contact: For MerckMedia:Pamela Eisele, 267-305-3558orCourtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE @Merck read more
Tags: high
positive
cell
treatment
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] next »